Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q1 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.